Phorbol ester-induced apoptosis and senescence in cancer cell models

被引:15
作者
Xiao, Liqing [1 ,2 ]
Caino, M. Cecilia [1 ,2 ]
von Burstin, Vivian A. [1 ,2 ]
Oliva, Jose L. [3 ]
Kazanietz, Marcelo G. [1 ,2 ]
机构
[1] Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Inst Translat Med & Therapeut, Sch Med, Philadelphia, PA 19104 USA
[3] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Biol Celular, Madrid, Spain
来源
PROGRAMMED CELL DEATH, THE BIOLOGY AND THERAPEUTIC IMPLICATIONS OF CELL DEATH, PART B | 2008年 / 446卷
关键词
D O I
10.1016/S0076-6879(08)01607-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinase C (PKC) isozymes catalyze the phosphorytation of substrates that play key roles in the control in proliferation, differentiation, and survival. Treatment of cells with phorbol esters, activators of classical and novel PKC isozymes, leads to a plethora of responses in a strict celt-type-dependent specific manner. Interestingly, a few cell models undergo apoptosis in response to phorbol ester stimulation, including androgen-dependent prostate cancer cells. This effect involves the autocrine secretion of death factors and activation of the extrinsic apoptotic cascade. We have recently found that in other models, such as lung cancer cells, phorbol esters lead to irreversible growth arrest and senescence. This chapter describes the methods we use to assess these phorbol ester responses in cancer cell models, focusing on apoptosis and senescence.
引用
收藏
页码:123 / 139
页数:17
相关论文
共 56 条
[31]  
Li LW, 1999, MOL CELL BIOL, V19, P8547
[32]   The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IκB kinase and c-Jun N-terminal kinase [J].
Lin, Y ;
Devin, A ;
Cook, A ;
Keane, MM ;
Kelliher, M ;
Lipkowitz, S ;
Liu, ZG .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (18) :6638-6645
[33]   Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation [J].
Lin, Y ;
Choksi, S ;
Shen, HM ;
Yang, QF ;
Hur, GM ;
Kim, YS ;
Tran, JH ;
Nedospasov, SA ;
Liu, ZG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) :10822-10828
[34]   Protein kinase Cε activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-α-induced cell death [J].
Lu, Dongmei ;
Huang, Jie ;
Basu, Alakananda .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (32) :22799-22807
[35]   Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-κB, elicits caspase activity, and enhances cytotoxicity [J].
Lüschen, S ;
Scherer, G ;
Ussat, S ;
Ungefroren, H ;
Adam-Klages, S .
EXPERIMENTAL CELL RESEARCH, 2004, 293 (02) :196-206
[36]  
MISCHAK H, 1993, J BIOL CHEM, V268, P6090
[37]   Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the η and δ isoforms of protein kinase C [J].
Ohba, M ;
Ishino, K ;
Kashiwagi, M ;
Kawabe, S ;
Chida, K ;
Huh, NH ;
Kuroki, T .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (09) :5199-5207
[38]   Protein kinase C-E: regulates the apoptosis and survival of glioma cells [J].
Okhrimenko, H ;
Lu, W ;
Xiang, CL ;
Hamburger, N ;
Kazimirsky, G ;
Brodie, C .
CANCER RESEARCH, 2005, 65 (16) :7301-7309
[39]   S-Phase-specific activation of PKCα induces senescence in non-small cell lung cancer cells [J].
Oliva, Jose L. ;
Caino, M. Cecilia ;
Senderowicz, Adrian M. ;
Kazanietz, Marcelo G. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (09) :5466-5476
[40]   Protein kinase c α but not PKCζ suppresses intestinal tumor formation in ApcMin/+ mice [J].
Oster, Henrik ;
Leitges, Michael .
CANCER RESEARCH, 2006, 66 (14) :6955-6963